The stock of Indivior PLC (LON:INDV) is a huge mover today! The stock increased 5.45% or GBX 19.09 on November 3, hitting GBX 369.49. About 5.00M shares traded hands or 120.26% up from the average. Indivior PLC (LON:INDV) has risen 121.22% since April 6, 2016 and is uptrending. It has outperformed by 120.01% the S&P500.
The move comes after 9 months positive chart setup for the GBX 2.65B company. It was reported on Nov, 3 by Barchart.com. We have GBX 550.54 PT which if reached, will make LON:INDV worth GBX 1.30 billion more.
Indivior PLC (LON:INDV) Ratings Coverage
Out of 8 analysts covering Indivior Plc (LON:INDV), 6 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 75% are positive. Indivior Plc has been the topic of 69 analyst reports since July 29, 2015 according to StockzIntelligence Inc. As per Thursday, February 18, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Friday, November 6 by Jefferies. Deutsche Bank maintained Indivior PLC (LON:INDV) on Thursday, December 10 with “Buy” rating. Deutsche Bank maintained Indivior PLC (LON:INDV) on Monday, March 7 with “Buy” rating. The rating was maintained by Jefferies with “Buy” on Monday, August 22. The stock of Indivior PLC (LON:INDV) earned “Buy” rating by Stifel Nicolaus on Wednesday, August 17. Numis Securities maintained the shares of INDV in a report on Thursday, November 3 with “Buy” rating. The rating was maintained by Cantor Fitzgerald with “Hold” on Wednesday, August 17. Numis Securities maintained Indivior PLC (LON:INDV) rating on Monday, September 26. Numis Securities has “Buy” rating and GBX 370 price target. The firm earned “Buy” rating on Monday, March 7 by Citigroup.
More important recent Indivior PLC (LON:INDV) news were published by: Prnewswire.com which released: “Indivior PLC Announces Positive Top-line Results From Pivotal Phase 3 Trial of …” on May 05, 2015, also Fool.Co.Uk published article titled: “Will Indivior plc (+71%), Serco Group plc (+33%) & Indus Gas Limited (+105 …”, Fool.Co.Uk published: “Are GlaxoSmithKline plc and Indivior plc the perfect pharma pairing?” on May 31, 2016. More interesting news about Indivior PLC (LON:INDV) was released by: Fool.Co.Uk and their article: “Indivior PLC Scraps Dividend: Should You Sell And Buy AstraZeneca plc Or Shire …” with publication date: February 18, 2016.
Indivior PLC is a specialty pharmaceutical company. The company has a market cap of 2.65 billion GBP. The Firm is engaged in the development, manufacture and sale of prescription drugs that are based on buprenorphine for treatment of opioid dependence segment. It currently has negative earnings. The Company’s treatment and pipeline focuses on opioid use disorder, alcohol use disorder, overdose rescue and co-morbidities of addiction/schizophrenia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.